Organogenesis Net Income From Continuing Ops from 2010 to 2024
| ORGO Stock | USD 2.75 0.07 2.61% |
Net Income From Continuing Ops | First Reported 2017-09-30 | Previous Quarter -568 K | Current Value -2.1 M | Quarterly Volatility 15.5 M |
Check Organogenesis Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organogenesis Holdings' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 2.1 M or Selling General Administrative of 146.1 M, as well as many indicators such as Price To Sales Ratio of 2.26, Dividend Yield of 0.0 or PTB Ratio of 1.83. Organogenesis financial statements analysis is a perfect complement when working with Organogenesis Holdings Valuation or Volatility modules.
Organogenesis | Net Income From Continuing Ops |
Latest Organogenesis Holdings' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Organogenesis Holdings over the last few years. It is Organogenesis Holdings' Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organogenesis Holdings' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Organogenesis Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (4,504,036) | |
| Geometric Mean | 13,476,502 | |
| Coefficient Of Variation | (795.83) | |
| Mean Deviation | 24,784,234 | |
| Median | (2,878,872) | |
| Standard Deviation | 35,844,382 | |
| Sample Variance | 1284.8T | |
| Range | 159.7M | |
| R-Value | 0.45 | |
| Mean Square Error | 1104.6T | |
| R-Squared | 0.20 | |
| Significance | 0.09 | |
| Slope | 3,599,191 | |
| Total Sum of Squares | 17987.5T |
Organogenesis Net Income From Continuing Ops History
About Organogenesis Holdings Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Organogenesis Holdings income statement, its balance sheet, and the statement of cash flows. Organogenesis Holdings investors use historical funamental indicators, such as Organogenesis Holdings's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Organogenesis Holdings investors may use each financial statement separately, they are all related. The changes in Organogenesis Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Organogenesis Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Organogenesis Holdings Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Organogenesis Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 13 M | 13.6 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Organogenesis Stock
When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock:Check out the analysis of Organogenesis Holdings Correlation against competitors. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.307 | Earnings Share 0.04 | Revenue Per Share 3.313 | Quarterly Revenue Growth 0.022 | Return On Assets 0.0201 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.